Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-arm GD31 study in hospitalized adults with COVID-19 pneumonia
ChiCTR2000029895Phase 2Recruiting
- Sponsor
- Guangzhou Eighth People's Hospital
- Start
- Feb 2020
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of GD31 in coronavirus pneumonia, sponsored by Guangzhou Eighth People's Hospital. Primary endpoint: Negative conversion rate and time to negative conversion of SARS-CoV-2 nucleic acid in throat swab at day 10. Started Feb 2020; status: recruiting.
02
Drugs
GD31
03
Conditions
coronavirus pneumonia
Beyond the preview
Go deeper on ChiCTR2000029895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029895.